#bevixa

[onuspharmabd]

Bevixa 400 mg Injection/16 ml | Bevacizumab - Onus Pharma

Bevixa 400 mg/16 mL is a biologic cancer therapy containing bevacizumab, a monoclonal antibody targeting VEGF to inhibit tumor angiogenesis. Administered via intravenous infusion, it’s indicated for conditions like metastatic colorectal, non‑squamous NSCLC, renal, ovarian, cervical cancers, and glioblastoma. Common side effects include hypertension, proteinuria, bleeding, headache, and dry skin.

Bevixa 400 mg Injection / 16 ml | Bevacizumab - Onus Pharma

Bevixa 400 mg (Injection) is a biologic medication. It is known as endothelial vascular growth factor receptor used to treat different types

[medsforcancer]

Bevixa | A Bevacizumab Biosimilar

Understand Biosimilar:

Biosimilars are new class of drugs that are highly similar to biologic. Which are not identical copies but close enough to use as alternative treatments. Biosimilars have some advantages

Lower cost: Biosimilars are comparatively lower in price than biologic one. So many patients can have access for these drugs. Where biologic one is not affordable for everyone.

Clinically similar: Extensive studies ensure bevacizumab biosimilars are highly similar to the original drug in terms of safety and effectiveness.

Physician discretion: Choosing the most suitable treatment option, including a biosimilar, is determined by the physician considering individual patient factors and treatment goals.

Consultation recommended: If you have any questions or concerns about bevacizumab biosimilars, consult your healthcare provider for personalized advice.

Bevixa as a biosimilar of Bevacizumab:

Bevacizumab is a biologic medication used to treat a certain types of cancers and specific eye disease. Which have been shown a very highly expensive where bevixa is a biosimilar to bevacizumab which is very close enough to treat as alternative of bevacizumab at an affordable cost. Bevixa is made in Bangladesh by incepta pharmaceutical, a renowned pharmaceutical in Bangladesh. Bevixa has a huge demand in global and local market because of its effectiveness and low price. So any one can have access to this medication.

Bevacizumab biosimilar ophthalmology

Bevacizumab is a multicancer treating medication. It is also used to treat a specific eye disease called wet age related macular degeneration and diabetic macular edema. But it has no FDA approval for using to treat ophthalmology.

To buy bevixa you may contact us at WhatsApp or Wechat [phone]